The 19 billion-dollar startups to watch that are revolutionizing healthcare in 2019

Healthcare startups saw some big changes in 2019. The robotics surgical company, Auris Health was bought by Johnson & Johnson and health insurance startup Oscar Health announced expansion in 12 new markets for next year.

There are 19 healthcare startups that have reached unicorn status - or the $1 billion and over valuation mark, according to PitchBook.

Some of the billion-dollar healthcare companies like 23andMe, Tempus, and One Medical on the list are worth watching as they revolutionize healthcare.

Click here for more BI Prime stories.

For private (and now public) healthcare and biotech companies, 2018 was a great year to raise capital with 16 companies reaching unicorn status. So far, in 2019, three more companies have been added to the list.

Health Catalyst, which went public in July, Lyell Therapeutics and Rakuten Medical all reached the $1 billion valuation mark.

Some significant changes happened in 2019, with Auris Health getting bought by Johnson & Johnson for $3.4 billion in February 2019, marking the company's valuation at over $5 billion. Tempus, the healthcare analytics platform, increased its valuation to $3 billion after less than four years. The health-insurance startup, Oscar Health, also announced plans to expand the company in 12 new markets next year.

According to data from PitchBook, here are the top-valued healthcare companies of 2019.

This list was initially published in December 2018 and has been updated.

Never miss out on healthcare news. Subscribe to Dispensed, our weekly newsletter on pharma, biotech, and healthcare.

医疗保健初创公司在2019年看到了一些重大变化。机器人外科公司Auris Health被强生公司收购，健康保险创业公司Oscar Health宣布明年在12个新市场扩张。据PitchBook报道，有19家医疗保健创业公司已达到独角兽地位 - 或10亿美元及以上的估值标志。一些价值数十亿美元的医疗保健公司，如名单上的23andMe，Tempus和One Medical，值得关注，因为它们正在改变医疗保健。 点击此处获取更多BI Prime故事。对于私人（现在是公共的）医疗保健和生物技术公司而言，2018年是筹集资金的重要一年，有16家公司达到独角兽地位。到目前为止，在2019年，还有三家公司被列入名单。 健康催化剂于7月上市，Lyell Therapeutics和Rakuten Medical均达到了10亿美元的估值。在2019年发生了一些重大变化，其中Auris Health在2019年2月被强生公司以34亿美元的价格收购，标志着该公司的估值超过50亿美元。医疗分析平台Tempus在不到四年的时间内将估值提高至30亿美元。健康保险创业公司Oscar Health也宣布计划明年将该公司扩展到12个新市场。 根据PitchBook的数据，这里是2019年的顶级医疗保健公司。该名单最初发布于2018年12月，并已更新。不要错过医疗保健新闻。订阅Dispensed，我们关于制药，生物技术和医疗保健的每周时事通讯。